103 related articles for article (PubMed ID: 1788748)
1. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
Rosak C; Hofmann U; König P; Nitsche GB
Vasa Suppl; 1991; 33():339-40. PubMed ID: 1788748
[No Abstract] [Full Text] [Related]
2. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
[No Abstract] [Full Text] [Related]
3. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
Thum J; Caspary L; Creutzig A; Alexander K
Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
[No Abstract] [Full Text] [Related]
4. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
[No Abstract] [Full Text] [Related]
5. Intravenous prostavasin--therapy in peripheral arterial occlusive disease in Fontaine's stages III and IV. Early and late results of a screening study.
Heidrich H; Meuche C; Ranft J; Rummel S; Peters A
Prog Clin Biol Res; 1989; 301():411-6. PubMed ID: 2678131
[No Abstract] [Full Text] [Related]
6. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
7. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
Hepp W; von Bary S; Corovic D; Diehm C; Mühe E; Rudofsky G; Scheffler P; Trübestein G; Vogelpohl M
Vasa Suppl; 1991; 33():348-9. PubMed ID: 1788753
[No Abstract] [Full Text] [Related]
8. [The effect of antiaggregants on the course of diabetic microangiopathy].
Bokarev IN; Velikov VK; Zelenchuk NM; Shubina OI; Saltykov BB; Frolova AI; Polunin GS; Pirogova EP; Nikol'skaia VV; Davydova NG
Ter Arkh; 1993; 65(3):78-81. PubMed ID: 8059393
[TBL] [Abstract][Full Text] [Related]
9. [Results of local thrombolysis with special reference to diabetic metabolism].
Stiegler H; Hufen V; Weichenhain B; Standl E; Mehnert H
Med Klin (Munich); 1990 Apr; 85(4):171-5, 228. PubMed ID: 2352521
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease.
Elias AN; Eng S
Diabetes Obes Metab; 2005 Mar; 7(2):117-21. PubMed ID: 15715884
[No Abstract] [Full Text] [Related]
11. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
Balzer K; Rogatti W; Rüttgerodt K
Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
[TBL] [Abstract][Full Text] [Related]
12. [Administration of prostaglandin E1 in diabetics and non-diabetic patients with severe Fontaine stage IIb arterial occlusive disease].
Hinderer S; Brachmann R; Nedder KH; Bucher J; Beischer W
Vasa; 1991; 20(2):100-8. PubMed ID: 1877328
[TBL] [Abstract][Full Text] [Related]
13. [Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].
Dé P; Hepp W
Vasa Suppl; 1990; 30():139-41. PubMed ID: 2075565
[No Abstract] [Full Text] [Related]
14. [Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent].
Freyberger H; Schifferdecker E; Schatz H
Med Klin (Munich); 1994 Nov; 89(11):594-7, 633. PubMed ID: 7815987
[TBL] [Abstract][Full Text] [Related]
15. [Macroangiopathy and microangiopathy in diabetes. I. Vascular changes in type 2 diabetics. Initial examination].
Spácil J; Páv J; Sperl M; Silinková-Málková E; Vancura J
Vnitr Lek; 1986 Sep; 32(9):894-900. PubMed ID: 3765427
[No Abstract] [Full Text] [Related]
16. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
Scheffler P; Birkel L; Grub KR; de la Hamette D
Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
[No Abstract] [Full Text] [Related]
17. [Arterial hypertension and diabetes].
Grimm JJ; Furrer J
Schweiz Med Wochenschr Suppl; 1994; 60():43-6. PubMed ID: 8016612
[No Abstract] [Full Text] [Related]
18. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
[TBL] [Abstract][Full Text] [Related]
19. [Calcinosis of arteries of the feet in diabetes mellitus].
Skotnikov VI; Kolesov VIu; Vulekh VM; Grigor'ev SV
Sov Med; 1988; (10):112-4. PubMed ID: 3242086
[No Abstract] [Full Text] [Related]
20. [Incidence and onset of arterial hypertension and diabetic retinopathy in a population of subjects with diabetes mellitus].
Repeti M; Urbani A; Barbaro D; Bassano G; Bernini F; Boldrin M; Crestini AM; Lombardo M; Marino O
Clin Ter; 1994 Jun; 144(6):511-5. PubMed ID: 8001335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
